Institutional members access full text with Ovid®

Share this article on:

Enoxaparin Treatment for Vulvodynia: A Randomized Controlled Trial

Rowland, Kathleen MD, MS

doi: 10.1097/AOG.0b013e3182851d69
Departments: Letters to the Editor

Department of Family Medicine, University of Chicago, Chicago, Illinois

Letters to the Editor Guidelines. Letters posing a question or challenge to an article appearing in Obstetrics & Gynecology should be submitted within 6 weeks of the article’s publication online. Letters received after 6 weeks will rarely be considered. Letters should not exceed 350 words, including signatures and 5 references. A word count should be provided. The maximum number of authors permitted is four, and a corresponding author should be designated (and contact information listed). Letters will be published at the discretion of the Editor. The Editor may send the letter to the authors of the original paper so their comments may be published simultaneously. The Editor reserves the right to edit and shorten letters. A signed author agreement form is required from all authors before publication. Letters should be submitted using the Obstetrics & Gynecology online submission and review system, Editorial Manager (http://ong.edmgr.com).

Financial Disclosure: The author did not report any potential conflicts of interest.

© 2013 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.